rFVII for pediatric acute intracranial hemorrhage [15]

Stroke

Volumn 38, Issue 7, 2007, Pages

  Perez Alvarez, Frederic ^a   Serra, Cristina ^a   Macia, Jaume ^a   Mayol, Lluis ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 7; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BRAIN HEMORRHAGE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; HEMORRHAGIC SHOCK; HUMAN; LETTER; LUNG HEMORRHAGE; MULTIPLE DRUG DOSE; PEDIATRICS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOSIS;

ADULT; AGED; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; INFANT; INFANT, NEWBORN; INTRACRANIAL HEMORRHAGES; MALE;

EID: 34347326226     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.484493     Document Type: Letter

References (10)

1. Mayer SA. Recombinant activated factor VII for acute intracerebral hemorrhage. Stroke. 2007;38:763-767.
2. Brady KM, Easley RB, Tobias JD. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Paediatr Anaesth. 2006;16:1042-1046.
3. Abdullah F, Hunter C, Hargrove C, Arnold M, Stein J. Recombinant factor VIIa for treatment of massive liver fracture in a premature infant. J Pediatr Surg. 2006;41:1764-1767.
4. Papa ML, Schisano G, Franco A, Nina P. Congenital deficiency of factor VII in subarachnoid hemorrhage. Stroke. 1994;25:508-510.
5. Mariani G, Konkle BA, Ingerslev J. Congenital factor VII deficiency: therapy with recombinant activated factor VII - a critical appraisal. Haemophilia. 2006;12:19-27.
6. Sosothikul D, Seksarn P, Lusher JM. Pediatric REFERENCE values for molecular Markers in Hemostasis. J Pediatr Hematol Oncol. 2007;29:19-22.
7. Tsuda T, Okamoto Y, Sakaguchi R, Katayama N, Ota K. Isolated factor VII deficiency diagnosed after a life-threatening brain haemorrhage. J Int Med Res. 2000;28:318-323.
8. Grizelj R, Vukovic J, Filipovic-Groic B, Saric D, Luetic T. Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. Blood Coagul Fibrinolysis. 2006;17:413-415.
9. Robertson JD. Prevention of intraventricular haemorrhage: a role for recombinant activated factor VII. J Paediatr Child Health. 2006;42:325-331.
10. Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke. 2006;37:2751-2758.